unknown
Stage
1
Investors
About
IFM Therapeutics develops novel immuno-oncology therapeutics focused on modulating the immune system to treat cancer and inflammatory diseases.
Explore IFM Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.